Outcome and Complications After Percutaneous Needle Versus Blade Achilles Tenotomy in Clubfoot Treated With the Ponseti Method

Sponsor
Indus Hospital and Health Network (Other)
Overall Status
Recruiting
CT.gov ID
NCT04897100
Collaborator
(none)
312
1
2
32.2
9.7

Study Details

Study Description

Brief Summary

Achilles tendon tenotomy is an integral part of the Ponseti method, aimed at correcting residual equinus after correction of the adductus deformity. Tenotomy rates ranging from 63-95% after full cycle of castings have been reported in literature. Percutaneous tenotomy is the gold standard, which can usually be performed in an out-patient setting under local anesthesia using a scalpel blade. A complication rate of 2% (mainly neurovascular injury)has been reported in literature, with accidental sectioning of the peroneal artery being the most common. Development of a pseudo-aneurysm after accidental sectioning of the peroneal artery has been reported in a case report; this delayed further clubfoot treatment.

Percutaneous needle tenotomy has been described by some authors as an alternative technique with very favorable results in a population before walking age. This technique use a large-gauge (16-19 G) needle to percutaneously cut the Achilles tendon. Although bleeding has been reported following this technique with similar rates as for the percutaneous blade technique, no major complications have been reported as yet using the needle technique.

We would like to compare the clinical outcomes and complication rates of both techniques, supporting our hypothesis that both techniques are equally safe and have the same success rate.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Achilles tendon tenotomy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
312 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Outcome and Complications After Percutaneous Needle Versus Blade Achilles Tenotomy in Clubfoot Treated With the Ponseti Method
Actual Study Start Date :
Mar 27, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Needle tenotomy

Procedure: Achilles tendon tenotomy
Achilles tendon tenotomy during Ponseti treatment for clubfoot

Active Comparator: Blade tenotomy

Procedure: Achilles tendon tenotomy
Achilles tendon tenotomy during Ponseti treatment for clubfoot

Outcome Measures

Primary Outcome Measures

  1. Dorsiflexion [6 months]

    Ankle dorsiflexion more or less than 20°

Secondary Outcome Measures

  1. Complications [6 months]

    Post-op complications due to tenotomy

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 36 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Idiopathic clubfoot.

  • Age less than or equal to 36 months at the time of tenotomy.

  • Enrolled at the Pehla Qadam clinic at The Indus Hospital in Karachi.

  • Fully corrected Adductus deformity with residual equinus after a full casting cycle.

  • Completing routine follow up for 3 months post tenotomy.

Exclusion Criteria:
  • Refusal of parents to enroll child into this study.

  • Syndromic clubfoot.

  • Previous treatment for clubfoot (surgical or non-surgical) received.

  • Underlying medical conditions unrelated to clubfoot that may serve as a contra-indication, this decision will be left on the discretion of the treating orthopedic surgeon

Contacts and Locations

Locations

Site City State Country Postal Code
1 Indus Hospital Karachi Sindh Pakistan

Sponsors and Collaborators

  • Indus Hospital and Health Network

Investigators

  • Principal Investigator: Mansoor Khan, Indus Hospital and Health Network

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Indus Hospital and Health Network
ClinicalTrials.gov Identifier:
NCT04897100
Other Study ID Numbers:
  • IRD_IRB_2020_03_011
First Posted:
May 21, 2021
Last Update Posted:
May 21, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 21, 2021